Insider Transactions in Q2 2024 at Emergent Bio Solutions Inc. (EBS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 08
2024
|
William Hartzel SVP, Bioservices |
SELL
Payment of exercise price or tax liability
|
Direct |
1,167
-3.4%
|
$7,002
$6.19 P/Share
|
|
Jun 08
2024
|
Richard S Lindahl EVP, Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,733
-1.72%
|
$16,398
$6.19 P/Share
|
|
Jun 08
2024
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
SELL
Payment of exercise price or tax liability
|
Direct |
1,249
-0.76%
|
$7,494
$6.19 P/Share
|
|
Jun 08
2024
|
Paul Anthony Williams SVP, Products Business |
SELL
Payment of exercise price or tax liability
|
Direct |
464
-1.86%
|
$2,784
$6.19 P/Share
|
|
Jun 08
2024
|
Jennifer Lynne Fox EVP, Ext Aff, GC, Corp Sec |
SELL
Payment of exercise price or tax liability
|
Direct |
2,376
-1.37%
|
$14,256
$6.19 P/Share
|
|
Jun 04
2024
|
Kathryn C Zoon Director |
SELL
Open market or private sale
|
Direct |
10,000
-15.51%
|
$60,000
$6.11 P/Share
|
|
May 29
2024
|
Kathryn C Zoon Director |
SELL
Open market or private sale
|
Direct |
1,830
-2.76%
|
$7,320
$4.61 P/Share
|
|
May 23
2024
|
Sujata Tyagi Dayal Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,430
+21.64%
|
-
|
|
May 23
2024
|
Marvin L White Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,430
+20.31%
|
-
|
|
May 23
2024
|
Donald W De Golyer Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,430
+11.35%
|
-
|
|
May 23
2024
|
Neal Franklin Fowler Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,430
+11.35%
|
-
|
|
May 23
2024
|
Keith Katkin Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,430
+22.55%
|
-
|
|
May 23
2024
|
Kathryn C Zoon Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,430
+20.81%
|
-
|
|
May 23
2024
|
Zsolt Harsanyi Chairman |
BUY
Grant, award, or other acquisition
|
Direct |
17,430
+16.33%
|
-
|
|
May 23
2024
|
Louis W Sullivan Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,430
+14.27%
|
-
|
|
May 23
2024
|
Ronald Richard Director |
BUY
Grant, award, or other acquisition
|
Direct |
17,430
+19.69%
|
-
|
|
May 21
2024
|
Kathryn C Zoon Director |
SELL
Open market or private sale
|
Direct |
1,089
-2.18%
|
$5,445
$5.78 P/Share
|
|
Apr 07
2024
|
William Hartzel SVP, Bioservices |
SELL
Payment of exercise price or tax liability
|
Direct |
665
-1.9%
|
$1,330
$2.29 P/Share
|
|
Apr 07
2024
|
Coleen Glessner EVP, Quality & Ethics, and CPL |
SELL
Payment of exercise price or tax liability
|
Direct |
585
-0.35%
|
$1,170
$2.29 P/Share
|